LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis
Open Access
- 5 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 19 (1), 1-8
- https://doi.org/10.1186/s12957-021-02279-2
Abstract
Background The incidence of gallbladder carcinoma (GBM) in China has increased in recent years. Here, the functional mechanism of lncRNA TTN-AS1 in GBC was preliminary elucidated. Methods The expression levels of lncRNA TTN-AS1, miR-107, and HMGA1 in tissues and cell lines were assessed by RT-qPCR. Cell proliferation was measured by MTT assays. Cell invasion and migration abilities were evaluated by Transwell assays. The relationship between miR-107 and lncRNA TTN-AS1 or HMGA1 was confirmed by luciferase reporter assay. Results Upregulation of lncRNA TTN-AS1 and downregulation of miR-107 were detected in GBC. Furthermore, the expressions between TTN-AS1 and miR-107 were mutually inhibited in GBC. Functionally, lncRNA TTN-AS1 promoted cell viability and motility in GBC by sponging miR-107. In addition, miR-107 directly targets HMGA1. And HMGA1 can be positively regulated by lncRNA TTN-AS1 in GBC. Furthermore, HMGA1 promoted GBC progression by interacting with lncRNA TTN-AS1/miR-107 axis. Conclusion LncRNA TTN-AS1 acted as a tumor promoter in GBC by sponging miR-107 and upregulating HMGA1.Keywords
This publication has 41 references indexed in Scilit:
- miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancerBiochemical and Biophysical Research Communications, 2016
- Association of Methylenetetrahydrafolate Reductase Gene Polymorphism (MTHFR) in Patients with Gallbladder CancerJournal of Gastrointestinal Cancer, 2015
- Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition.2015
- MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1Cellular Physiology and Biochemistry, 2014
- Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder CarcinomaAnnals of Surgical Oncology, 2013
- miR‐26a inhibits proliferation and motility in bladder cancer by targeting HMGA1FEBS Letters, 2013
- Current Management of Gallbladder CarcinomaThe Oncologist, 2010
- Environmental pollutants in gallbladder carcinogenesisJournal of Surgical Oncology, 2006
- Gallbladder cancer: lessons from a rare tumourNature Reviews Cancer, 2004
- Epidemiology and Molecular Pathology of Gallbladder CancerCA: A Cancer Journal for Clinicians, 2001